Tredje AP fonden Decreases Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Tredje AP fonden reduced its position in Molina Healthcare, Inc. (NYSE:MOH) by 50.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 4,544 shares of the company’s stock after selling 4,543 shares during the period. Tredje AP fonden’s holdings in Molina Healthcare were worth $1,323,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in MOH. Janney Montgomery Scott LLC lifted its holdings in shares of Molina Healthcare by 3.0% in the 3rd quarter. Janney Montgomery Scott LLC now owns 2,509 shares of the company’s stock valued at $865,000 after purchasing an additional 72 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in shares of Molina Healthcare by 57.4% in the 3rd quarter. GSA Capital Partners LLP now owns 3,620 shares of the company’s stock valued at $1,247,000 after purchasing an additional 1,320 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Molina Healthcare by 1.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 146,335 shares of the company’s stock valued at $50,421,000 after purchasing an additional 1,778 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Molina Healthcare by 6.5% in the 3rd quarter. Victory Capital Management Inc. now owns 94,834 shares of the company’s stock valued at $32,676,000 after purchasing an additional 5,751 shares during the last quarter. Finally, Metis Global Partners LLC lifted its holdings in shares of Molina Healthcare by 1.4% in the 3rd quarter. Metis Global Partners LLC now owns 2,785 shares of the company’s stock valued at $960,000 after purchasing an additional 39 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.11% of the company’s stock.

Molina Healthcare Stock Performance

MOH opened at $308.51 on Friday. The stock has a market cap of $17.12 billion, a P/E ratio of 15.10, a P/E/G ratio of 1.06 and a beta of 0.56. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The stock’s 50 day simple moving average is $297.78 and its 200 day simple moving average is $311.20. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $423.92.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on MOH shares. Truist Financial dropped their price target on Molina Healthcare from $370.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, February 19th. UBS Group dropped their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. Barclays dropped their price target on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a research report on Friday, February 7th. Mizuho dropped their price target on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Finally, Wells Fargo & Company upgraded Molina Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, seven have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $355.69.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.